Inventor · disambiguated record
John Messenheimer
Also filed as: MESSENHEIMER JOHN
7 granted patents·13 pending applications·54 citations·filing 2018–2025
86Inventor score
Top patents by PatentIndex Score
20 records- 0195US11458110B2Treatment of Fragile X Syndrome with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2020·Granted Oct 4, 2022·4 cites·7 claims
- 0295US10758497B2Treatment of fragile x syndrome with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2019·Granted Sep 1, 2020·14 cites·7 claims
- 0394US11779549B2Treatment of Fragile X Syndrome with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2022·Granted Oct 10, 2023·2 cites·2 claims
- 0494US10471022B2Treatment of fragile X syndrome with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2019·Granted Nov 12, 2019·14 cites·6 claims
- 0594US10213390B1Treatment of fragile X syndrome with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2018·Granted Feb 26, 2019·19 cites·8 claims
- 0692US12226373B2Treatment of fragile X syndrome with cannabidiolHARMONY BIOSCIENCES MAN INC·Filed 2023·Granted Feb 18, 2025·1 cites·8 claims
- 0782US2025213465A1Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adultsZYNERBA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0882US2025339450A1Treatment of syngap1 encephalopathyHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
- 0977US12508270B2Treatment of behavioral impairment in developmental and epileptic encephalopathyHARMONY BIOSCIENCES MAN INC·Filed 2022·Granted Dec 30, 2025·0 cites·14 claims
- 1077US2024148669A1Methods of treatment of osteoarthritis with transdermal cannabidiol gelZYNERBA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1176US2024189255A1Methods of treatment of osteoarthritis with transdermal cannabidiol gelZYNERBA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1274US2025134833A1Treatment of fragile x syndrome with cannabidiolHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
- 1374US2025195451A1Treatment of syngap1 encephalopathyHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
- 1469US2021077421A1Treatment of syngap1 encephalopathyZYNERBA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1569US2025302734A1Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adultsHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
- 1667US2019083388A1Synthentic transdermal cannabidiol for the treatment of focal epilepsy in adultsZYNERBA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1766US2021030665A1Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adultsZYNERBA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1864US2025268843A1Methods of treatment of osteoarthritis with transdermal cannabidiol gelHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
- 1960US2020170963A1Methods of treatment of osteoarthritis with transdermal cannabidiol gelZYNERBA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2046US2025177322A1Treatment of fragile x syndrome with cannabidiolHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Messenheimer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →